Analyst Price Targets — MD
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 24, 2026 12:59 pm | — | UBS | $22.00 | $19.20 | TheFly | Pediatrix Medical price target lowered to $22 from $23 at UBS |
| February 20, 2026 1:32 pm | — | Deutsche Bank | $19.00 | $18.80 | TheFly | Pediatrix Medical price target lowered to $19 from $21 at Deutsche Bank |
| February 19, 2026 6:04 pm | — | Truist Financial | $21.00 | $18.41 | TheFly | Pediatrix Medical price target lowered to $21 from $24 at Truist |
| November 10, 2025 3:04 pm | David MacDonald | Truist Financial | $24.00 | $22.30 | TheFly | Pediatrix Medical price target raised to $24 from $17 at Truist |
| November 5, 2025 2:27 pm | — | UBS | $23.00 | $21.46 | TheFly | Pediatrix Medical price target raised to $23 from $16.50 at UBS |
| October 14, 2025 1:22 pm | David MacDonald | Truist Financial | $17.00 | $16.04 | TheFly | Pediatrix Medical price target raised to $17 from $16 at Truist |
| October 7, 2024 7:11 am | David MacDonald | Truist Financial | $13.00 | $12.13 | TheFly | Pediatrix Medical price target raised to $13 from $10 at Truist |
| September 26, 2024 6:19 am | Jack Slevin | Jefferies | $14.00 | $11.26 | StreetInsider | Jefferies Upgrades Pediatrix Medical Group (MD) to Buy |
| August 15, 2024 8:17 am | David MacDonald | Truist Financial | $10.00 | $10.16 | StreetInsider | Pediatrix Medical Group (MD) PT Raised to $10 at Truist Securities |
| June 7, 2024 7:21 am | Pito Chickering | Deutsche Bank | $8.00 | $6.89 | StreetInsider | Deutsche Bank Upgrades Pediatrix Medical Group (MD) to Hold |
Latest News for MD
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Dana Investment Advisors Inc. increased its holdings in shares of Pediatrix Medical Group, Inc. (NYSE: MD) by 5.6% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 801,462 shares of the company's stock after buying an additional 42,162 shares
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group Announces 47th Annual NEO: The Conference for Neonatology.
Establishment Labs (NASDAQ: ESTA - Get Free Report) and Pediatrix Medical Group (NYSE: MD - Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, profitability, risk, analyst recommendations, valuation, institutional ownership and dividends. Profitability This table compares Establishment Labs and
MD's Q4 EPS miss estimates as revenues dip, but same-unit gains and a stronger 2026 EBITDA outlook signal mixed momentum.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for MD.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.